Face to Face Hot Stocks: Bed Bath & Beyond Inc. (NASDAQ:BBBY), Kala Pharmaceuticals, Inc. (NASDAQ:KALA)

Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Bed Bath & Beyond Inc. (NASDAQ:BBBY) closed at $17.29 on the last trading session with an increase of 2.43%, whereas, it previously closed at $16.88. The company has a market capitalization of $2.31 Billion. The company traded shares of 6.18 Million on the trading day while its three month average volume stands at 7.23 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) produced diluted EPS of 2.32. The EPS estimate for next year as estimated by analysts is at 1.79 while EPS for next quarter is estimated at 1.11. Earnings per Share growth for this year is reported at -31.9, while the analysts estimated the EPS growth for next year at 1.79% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -7.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Bed Bath & Beyond Inc. (NASDAQ:BBBY) is at 7.46 while the forward p/e is at 9.65. The P/S or Price to Sales ratio of Bed Bath & Beyond Inc. (NASDAQ:BBBY) stands at 0.19 and Price to Book or P/B for the most recent quarter stands at 0.8. The Price to Free Cash Flow ratio or P/FCF is reported at 3.99. The quick ratio and the current ratio of Bed Bath & Beyond Inc. (NASDAQ:BBBY) are reported at 0.6 and 1.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Bed Bath & Beyond Inc. (NASDAQ:BBBY) stands at 4.3, 10.7 and 11.4 respectively

The trailing twelve month Revenue of Bed Bath & Beyond Inc. (NASDAQ:BBBY) is reported at 12.44 Billion with income of 317.9 Million. The outstanding shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) are 133.81 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 2.54 in the last six months. The insider ownership for the shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) is ticked at 0.2%, the figure is plummeted -6.81% in the last six months.

Some other important financial aspects to be discussed here for Bed Bath & Beyond Inc. (NASDAQ:BBBY) is the Mean Target Price estimated by the analysts which stands at 15.8. The 52 week high of Bed Bath & Beyond Inc. (NASDAQ:BBBY) is placed at 21.44 and 52 week low is standing at 10.46.

Performance wise the shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell down -6.39% for the week, it also rise 23.5% for the monthly performance, while for the quarter it went down 15.19%. The shares increase 27.79% for the half year and flew up for the Year-To-Date performance. The shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) shrinked -1.14% for the yearly performance.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) closed at $7.92 on the last trading session with an decrease of -1.25%, whereas, it previously closed at $8.02. The company has a market capitalization of $266.19 Million. The company traded shares of 102468 on the trading day while its three month average volume stands at 227.53 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) produced diluted EPS of -2.45. The EPS estimate for next year as estimated by analysts is at -2.06 while EPS for next quarter is estimated at -0.75. Earnings per Share growth for this year is reported at 59.2, while the analysts estimated the EPS growth for next year at -2.06% and Earnings growth for next 5 years stands at 37.1% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -40.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) stands at 0 and Price to Book or P/B for the most recent quarter stands at 2.51. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) are reported at 10.2 and 10.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) stands at -52.8, -86.6 and 0 respectively

The trailing twelve month Revenue of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is reported at 0 with income of -66700000. The outstanding shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) are 33.61 Million. The institutional Ownership of the shares of 81.4 stands at 0.80%, this figure is decreased -0.02 in the last six months. The insider ownership for the shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is ticked at 4.25%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is the Mean Target Price estimated by the analysts which stands at 21.67. The 52 week high of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is placed at 17.53 and 52 week low is standing at 4.03.

Performance wise the shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) fell down -3.3% for the week, it also fell -7.26% for the monthly performance, while for the quarter it went down 26.92%. The shares decrease -7.48% for the half year and flew up for the Year-To-Date performance. The shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shrinked -52.2% for the yearly performance.